KirstenHEdmistonMD

General Surgery • Fairfax, VA

Breast, Surgical Oncology (Other than Breast)

Physician

Join to view full profile

Dr. Edmiston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Edmiston's full profile

Already have an account?

Office
3580 Joseph Siewick Dr
101
Fairfax, VA 22033
Phone+1 571-472-1600

Fax+1 703-391-4159
Is this information wrong?

Education & Training

University of MarylandResidency, Surgery, 1988 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1988

Certifications & Licensure

CA State Medical License 1993 - Present
VA State Medical License 1997 - 2024
American Board of Surgery Surgery

Awards, Honors, & Recognition

Fellow American College of Surgeons

Clinical Trials

New Individualized Therapy Trial for Metastatic Colorectal Cancer Start of enrollment: 2009 Jun 01
Completed
Phase 1, Phase 2
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Start of enrollment: 2009 Dec 01
Completed
Phase 1, Phase 2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Recruiting
Phase 2

Publications & Presentations

PubMed

20 citations
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Mi...> ;JAMA Oncology. 2021 Sep 16
2 citations
Ductal carcinoma in situ in the male‐to‐female transgender population
Arielle Stafford, Abbas Shobieri, Michael Stamatakos, Kirsten K. Edmiston> ;Breast Journal. 2020 Dec 4
2 citations
Innovations in Clinical Trial Design in the Era of Molecular Profiling.
Julia Wulfkuhle, Alexander Spira, Kirsten H. Edmiston, Emanuel F. Petricoin> ;Methods of Molecular Biology. 2017 Jan 1
73 citations
The neoadjuvant model is still the future for drug development in breast cancer
Angela De Michele, Douglas Yee, Donald A. Berry, Kathy S. Albain, Christopher C. Benz, Judy C. Boughey, Meredith Buxton, Stephen Chia, Amy Jo Chien, Stephen Y. Chui, A...> ;Clinical Cancer Research. 2015 Feb 24
Non-enzymatic, serum-free tissue culture of pre-invasive breast lesions for spontaneous generation of mammospheres.
Virginia Espina, Kirsten H. Edmiston, Lance A. Liotta> ;Journal of Visualized Experiments. 2014 Nov 8
26 citations
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients...
M. Pierobon, Alessandra Silvestri, Alexander I. Spira, Alex Reeder, Elisa Pin, S. Banks, Erika Maria Parasido, Kirsten H. Edmiston, Lance A. Liotta, E. Petricoin> ;Journal of Proteome Research. 2014 May 14
6 citations
Attacking breast cancer at the preinvasion stage by targeting autophagy.
Virginia Espina, John J. Wysolmerski, Kirsten H. Edmiston, Lance A. Liotta> ;Women's Health. 2013 Mar 1
2 citations
Clinical trial design in the age of molecular profiling
Alexander Spira, Kirsten H. Edmiston> ;Methods of Molecular Biology. 2012 Jan 1
57 citations
One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens.
Claudius Mueller, Kirsten H. Edmiston, Calvin Carpenter, Eoin F. Gaffney, Ciara Ryan, Ronan Ward, Susan White, Lorenzo Memeo, Cristina Colarossi, Emanuel F. Petricoin,...> ;PLOS ONE. 2011 Aug 17
11 citations
Breast cancer stem cells: a new target for therapy.
Giulia Federici, Virginia Espina, Lance A. Liotta, Kirsten H. Edmiston> ;Oncology. 2011 Jan 15
107 citations
Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival
Virginia Espina, Brian D. Mariani, Rosa I. Gallagher, Khoa D. Tran, S. Banks, Joy Wiedemann, Heather Huryk, Claudius Mueller, Luana Adamo, Jianghong Deng, Emanuel F. P...> ;PLOS ONE. 2010 Apr 20
67 citations
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability.
Virginia Espina, Claudius Mueller, Kirsten H. Edmiston, Manuela Sciro, Emanuel F. Petricoin, Lance A. Liotta> ;Proteomics Clinical Applications. 2009 Aug 1
161 citations
A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process
Virginia Espina, Kirsten H. Edmiston, Michael Heiby, Mariaelena Pierobon, Manuela Sciro, Barbara Merritt, S. Banks, Jianghong Deng, Amy VanMeter, David Geho, Lucia Pas...> ;Molecular & Cellular Proteomics. 2008 Oct 1
11 citations
Molecular network analysis using reverse phase protein microarrays for patient tailored therapy.
Runa Speer, Julia D. Wulfkuhle, Virginia Espina, Robyn Aurajo, Kirsten H. Edmiston, Lance A. Liotta, Emanuel F. Petricoin> ;Advances in Experimental Medicine and Biology. 2008 Jan 1
20 citations
Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.
Runa Speer, Julia D. Wulfkuhle, Virginia Espina, Robyn Aurajo, Kirsten H. Edmiston, Lance A. Liotta, Emanuel F. Petricoin> ;Cancer Genomics & Proteomics. 2007 May 1
93 citations
Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
Julia D. Wulfkuhle, Kirsten H. Edmiston, Lance A. Liotta, Emanuel F. Petricoin> ;Nature Reviews Clinical Oncology. 2006 May 1
22 citations
Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells.
John Milburn Jessup, Luciana Laguinge, Shuling Lin, Raed N. Samara, Kimberly Aufman, Paul Battle, Marilyn Frantz, Kirsten H. Edmiston, Peter Thomas> ;International Journal of Cancer. 2004 Sep 1
Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life.
Qiu, L., Low, H. P., Chang, C. I., Strohsnitter, W. C., Anderson, M., Edmiston, K., Adami, H. O., Ekbom, A., Hall, P., Lagiou, P., Trichopoulos, D., Hsieh, C. C.> ;Ann Oncol. 2012 Jan
Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk.
Strohsnitter, W. C., Savarese, T. M., Low, H. P., Chelmow, D. P., Lagiou, P., Lambe, M., Edmiston, K., Liu, Q., Baik, I., Noller, K. L., Adami, H. O., Trichopoulos, D....> ;Br J Cancer. 2008 Feb 12
Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells.
Jessup, J. M., Ishii, S., Mitzoi, T., Edmiston, K. H., Shoji, Y.> ;Clin Exp Metastasis. 1999
Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells.
Jessup, J. M., Battle, P., Waller, H., Edmiston, K. H., Stolz, D. B., Watkins, S. C., Locker, J., Skena, K.> ;Cancer Res. 1999 Apr 15
Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells.
Edmiston, K. H., Shoji, Y., Mizoi, T., Ford, R., Nachman, A., Jessup, J. M.> ;Cancer Res. 1998 Apr 1
In vivo induction of murine cytokine production by carcinoembryonic antigen.
Edmiston, K. H., Gangopadhyay, A., Shoji, Y., Nachman, A. P., Thomas, P., Jessup, J. M.> ;Cancer Res. 1997 Oct 1
Join now to see all

Press Mentions

Virginia Hospital Uses Patients’ DNA to Customize TreatmentNovember 13th, 2018
George Mason University Breast Cancer Treatment Patent Licensed by Targeted PharmaceuticalsJuly 23rd, 2019
New Quality Verification Program for Hospitals Will Benefit Participants in ACS NSQIPNovember 4th, 2021